Citi Pharma Ltd. Reports Strong Growth Despite Market Challenges

Karachi, Citi Pharma Ltd. has shown commendable performance with an earnings per share growth to Rs 2.88 from Rs 2.70 in the previous year, reflecting a positive trajectory amid challenging market conditions. Currently, the company’s stock is priced at Rs 2,284.61, and a 25% stock dividend has been announced. The firm, listed in 2021, is one of the newer entrants on the Pakistan Stock Exchange and closed its books on October 20, 2023.

Check Also

PSX Announces January 2025 Deliverable Future Contracts Schedule

Karachi: The Pakistan Stock Exchange (PSX) has released the trading and settlement schedule for Deliverable Future Contracts (DFC) for January 2025. The schedule details the opening and closing dates for contracts, alongside specific trading regulatio...

The post PSX Announces January 2025 Deliverable Future Contracts Schedule appeared first on .